• Tuesday, May 8th

• PDL BioPharma to Present at Upcoming Conferences
  PR Newswire (May 8, 2012)

• Thursday, May 3rd

• PDL BioPharma Announces First Quarter 2012 Financial Results
  PR Newswire (May 3, 2012)

• Friday, April 27th

• PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012
  PR Newswire (Apr 27, 2012)

• Thursday, April 26th

• PDL BioPharma Appoints Bruce Tomlinson as Chief Financial Officer
  PR Newswire (Apr 26, 2012)

• Thursday, April 12th

• PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012
  PR Newswire (Apr 12, 2012)

• Wednesday, March 14th

• PDL BioPharma Completes Regular Quarterly Dividend Payment
  PR Newswire (Mar 14, 2012)

• Tuesday, January 24th

• PDL BioPharma Announces 2012 Regular Quarterly Dividends
  PR Newswire (Jan 24, 2012)

• Thursday, January 5th

• PDL BioPharma Announces Settlement and Final Results of its Exchange Offer
  PR Newswire (Jan 5, 2012)
• PDL BioPharma to Present at the 30th Annual JP Morgan Healthcare Conference
  PR Newswire (Jan 5, 2012)

• Tuesday, January 3rd

• PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
  PR Newswire (Jan 3, 2012)

• Monday, December 19th, 2011

• PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million
  PR Newswire (Dec 19, 2011)

• Thursday, December 15th, 2011

• PDL BioPharma Completes Regular Quarterly Dividend Payment
  PR Newswire (Dec 15, 2011)

• Monday, December 12th, 2011

• PDL BioPharma Announces Departure of Chief Financial Officer
  PR Newswire (Dec 12, 2011)
• PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes
  PR Newswire (Dec 12, 2011)

• Wednesday, December 7th, 2011

• PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
  PR Newswire (Dec 7, 2011)